From 2009 to 2019, a total of 68 patients with TFE3-tRCC were identified from 4581 RCC cases (Supplementary Figure 1). This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.